drugset / Trial / NCT00692614

A Study of MK0140 in Diabetic Patients With Macular Edema (0140-001)

NCT00692614

Phase 2 Terminated 2 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will evaluate the treatment effect of three doses of the I-vation TA implant (MK0140) in diabetic patients with clinically significant macular edema.

Timeline

Start
2008-06
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified 100 ug
Subject Triamcinolone Acetonide Other / unclassified 500 ug
Subject Triamcinolone Acetonide Other / unclassified 925 ug

Indications